NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
1-Year Return
32.9%
This Quarter Return
+11.33%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.02B
AUM Growth
+$21.8M
(+2.2%)
Cap. Flow
-$93.3M
Cap. Flow
% of AUM
-9.14%
Top 10 Holdings %
Top 10 Hldgs %
46.08%
Holding
137
New
19
Increased
22
Reduced
37
Closed
18
Top Buys
| 1 |
Peloton Interactive
PTON
|
$13.1M |
| 2 |
Tourmaline Bio
TRML
|
$6.64M |
| 3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$6.6M |
| 4 |
eHealth
EHTH
|
$5.55M |
| 5 |
CONN
Conn's Inc.
CONN
|
$4.73M |
Top Sells
| 1 |
Establishment Labs
ESTA
|
$25.7M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$19.7M |
| 3 |
Soleno Therapeutics
SLNO
|
$19.1M |
| 4 |
Luxfer Holdings
LXFR
|
$11.7M |
| 5 |
Cytokinetics
CYTK
|
$9.19M |
Sector Composition
| 1 | Healthcare | 63.23% |
| 2 | Consumer Discretionary | 13.84% |
| 3 | Financials | 7.05% |
| 4 | Communication Services | 5.88% |
| 5 | Technology | 3.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Talphera
TLPH
$11.3M
| $2.05M | 0.12% |
1,992,519
+755,000
| +61% | +$778K |
|
|
RNTX
77
Rein Therapeutics, Inc. Common Stock
RNTX
$31M
| $1.69M | 0.1% |
+255,000
| New | +$1.69M |
|
|
IMTXW
78
DELISTED
Immatics N.V. Warrants
IMTXW
| $1.51M | 0.09% |
558,977
| – | – |
|
79
Scully Royalty
SRL
$80.8M
| $1.47M | 0.08% |
239,197
-3,524
| -1% | -$21.7K |
|
80
Anebulo Pharmaceuticals
ANEB
$97.8M
| $1.47M | 0.08% |
511,073
| – | – |
|
81
NeuroOne Medical Technologies
NMTC
$39.6M
| $1.44M | 0.08% |
1,198,912
-15,182
| -1% | -$18.2K |
|
82
Perella Weinberg Partners
PWP
$1.39B
| $1.41M | 0.08% |
99,778
-55,931
| -36% | -$790K |
|
83
Aprea Therapeutics
APRE
$9.03M
| $1.38M | 0.08% |
+205,760
| New | +$1.38M |
|
84
Instil Bio
TIL
$213M
| $1.37M | 0.08% |
127,292
| – | – |
|
85
Kiora Pharmaceuticals
KPRX
$9.2M
| $1.34M | 0.08% |
+211,111
| New | +$1.34M |
|
86
Fossil Group
FOSL
$165M
| $1.33M | 0.08% |
1,306,338
+901,060
| +222% | +$919K |
|
87
B. Riley Financial
RILY
$152M
| $1.32M | 0.08% |
62,520
| – | – |
|
|
MTTR
88
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $1.24M | 0.07% |
+548,376
| New | +$1.24M |
|
89
Strata Skin Sciences
SSKN
$7.42M
| $1.17M | 0.07% |
308,982
-3,831
| -1% | -$14.5K |
|
90
Children's Place
PLCE
$121M
| $1.15M | 0.07% |
+100,000
| New | +$1.15M |
|
91
SPAR Group
SGRP
$28.2M
| $897K | 0.05% |
879,189
| – | – |
|
92
Gossamer Bio
GOSS
$668M
| $794K | 0.05% |
672,856
| – | – |
|
93
Fortress Biotech
FBIO
$110M
| $556K | 0.03% |
278,152
-94,410
| -25% | -$189K |
|
94
Perfect Corp
PERF
$196M
| $496K | 0.03% |
+200,000
| New | +$496K |
|
95
Evoke Pharma
EVOK
$8.12M
| $412K | 0.02% |
+56,250
| New | +$412K |
|
96
AN2 Therapeutics
ANTX
$34.4M
| $319K | 0.02% |
98,278
-150,000
| -60% | -$488K |
|
|
LADR
97
Ladder Capital
LADR
$1.51B
| $285K | 0.02% |
25,631
| – | – |
|
98
Edgewise Therapeutics
EWTX
$1.64B
| $244K | 0.01% |
+13,371
| New | +$244K |
|
|
APTO
99
DELISTED
Aptose Biosciences, Inc.
APTO
| $147K | 0.01% |
2,951
-1,053
| -26% | -$52.4K |
|
100
Lucid Diagnostics
LUCD
$140M
| $132K | 0.01% |
149,698
| – | – |
|